Revium Rx Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2009	FY 2008
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008
Net Income	-0.68	-1.21	-0.1	0.1
Depreciation & Amortization	0	0	-	-
Stock-Based Compensation	0.05	0.29	-	-
Other Operating Activities	-	0.06	0	-0
Change in Accounts Receivable	-	-	0.27	-0.39
Change in Inventory	-	-	0.46	-0.76
Change in Accounts Payable	0.01	-0	0.07	0.34
Change in Other Net Operating Assets	-0.01	0.04	2.53	-5.06
Operating Cash Flow	-0.63	-0.82	3.23	-5.77
Capital Expenditures	-0	-0	-	-2.67
Sale of Property, Plant & Equipment	-	-	2	-
Investment in Securities	-4.95	-	-	-
Investing Cash Flow	-4.95	-0	2	-2.67
Total Debt Issued	-	-	-	0.41
Long-Term Debt Repaid	-	-	-0.11	-
Net Debt Issued (Repaid)	-	-	-0.11	0.41
Issuance of Common Stock	5.68	0.38	-	8.05
Repurchase of Common Stock	-	-	-0.01	-
Other Financing Activities	-	-	-5.13	-
Financing Cash Flow	5.68	0.38	-5.25	8.46
Net Cash Flow	0.1	-0.45	-0.02	0.02
Free Cash Flow	-0.63	-0.82	3.23	-8.44
Free Cash Flow Margin	-	-	491.85%	-283.08%
Free Cash Flow Per Share	-0.02	-0.03	55.51	-122.21
Levered Free Cash Flow	-0.42	-	0.18	-
Unlevered Free Cash Flow	-0.42	-	0.18	-
Change in Net Working Capital	0.04	-	-0.25	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.